ChoiceSpine has announced that it has received clearance from the US Food and Drug Administration (FDA) to market the Blackhawk Ti cervical spacer system.
According to ChoiceSpine, Blackhawk Ti is the first to market 3D-printed system that utilises preassembled integrated anchor technology, and is a new addition to the firm’s 3D-printed titanium fusion solutions portfolio.
Anders Cohen, the lead design surgeon for the Blackhawk Ti system, said: “Blackhawk Ti improves and builds upon the already successful original Blackhawk PEEK device with integrated anchor technology. The addition of 3D-printed porous titanium technology, and the implant’s unique updated design both play a role in the bone growth process during fusion.
“However, what really sets this system apart from others is the simplicity of the implant design and instrumentation that help to significantly reduce surgery time by decreasing the number of steps in the procedure.”
Steve Ainsworth, ChoiceSpine’s executive vice president of strategy and technology, added: “We are excited to announce the launch of our newest 3D-printed cervical spacer system.”
